In summary, our findings reveal a novel involvement of LOX/LOXL family of enzymes in migration and angiogenic properties of both normal and tumor-associated pericytes, supporting the exploration of LOX/LOXL inhibitors to target activation of pericytes within the TME. Here, LOX is linked to neoplasm.